CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 90 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $11,000 | +266.7% | 1,700 | +325.0% | 0.00% | – |
| Q2 2020 | $3,000 | -57.1% | 400 | -34.5% | 0.00% | – |
| Q2 2019 | $7,000 | +600.0% | 611 | +748.6% | 0.00% | – |
| Q3 2018 | $1,000 | -99.6% | 72 | -99.3% | 0.00% | -100.0% |
| Q2 2018 | $239,000 | +602.9% | 10,457 | +769.2% | 0.02% | +650.0% |
| Q1 2018 | $34,000 | +325.0% | 1,203 | +200.0% | 0.00% | +100.0% |
| Q4 2017 | $8,000 | +60.0% | 401 | +33.7% | 0.00% | – |
| Q2 2017 | $5,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |